|
PI3Kα Inhibitors for the Treatment of Cancer
Application
Compounds that inhibit the kinase activity of phospoinostidie 3-kinase (PI3Kα) for the treatment of cancer.
Key Benefits
Potential therapeutic targeted to pathway without a clinically approved inhibitor.
Provides a useful pharmacological probe for research purposes.
Market Summary
In order to grow, cancer cells must have the...
Published: 7/28/2023
Contributor(s): Qi Shi, Thomas Kaiser, Dennis Liotta, James Snyder, Zackery Dentmon, John Diraddo
|